What prompted the recall at Able Labs?

USA Today examines the strange case of Able Laboratories, the generic drug maker which pulled all of its drugs from the market in one of the biggest recalls ever to hit the business. But a month after the recall, after Able's stock has fallen 86%, little is known about what prompted the recall or what Able needs to do to fix the problem. Some of the most important unanswered questions lie with the FDA, which repeatedly inspected Able's facilities without raising any concerns.

- read this story from USA Today

Suggested Articles

Sarepta will negotiate a warning for golodirsen rather than carry out more studies. But the implications of the rejection range beyond golodirsen.

The Pfizer Foundation has awarded 20 grants to organizations involved in tackling infectious diseases in low- and middle-income countries.

The engineered stain of E. coli performed no better than placebo, leading Synlogic to conclude its money is better spent on other assets.